Method of producing manъs insulin or analogues thereof

专利摘要:
A process for the production of insulin or an insulin analog is provided by combination of an A-chain and a B-chain, which comprises reacting the S-sulfonated form of the A-chain, the S-sulfonated form of the B-chain, and a thiol. reducing agent together in an aqueous medium under conditions which produce a mixture having (1) a pH of from about 8 to about 12, (2) a total protein concentration of from about 0.1 to about 50 milligrams per milliliter, and (3) an amount of thiol reducing agent which affords a total of from about 0.4 to about 2.5 -SH groups per each -SSO3<-> group present in the total amount of A- and B-chain S-sulfonates, and allowing formation of insulin or an insulin analog to occur by maintaining the mixture at a temperature of from about 0 DEG C. to about 25 DEG C. and in an environment which provides a source of oxygen.
公开号:SU1327790A3
申请号:SU813269596
申请日:1981-03-26
公开日:1987-07-30
发明作者:Юджин Чанс Рональд；Артур Хоффманн Джеймс
申请人:Эли Лилли Энд Компани (Фирма)；
IPC主号:

专利说明:

The invention relates to an improved method for producing human insulin or its analogs of a biologically active compound, which finds application in medicine.
The purpose of the invention is to simplify the process and increase the yield of the target product.
Example 1. Porcine insulin A chain s-sulfonate (360 mg) was dissolved in 36 ml of 0.1 M glycine buffer (pH 10.5) and the mixture was adjusted to pH 10.5
The pH of each solution was adjusted to 10.5 with 5 H.-NaOH. DTT (61.7 mg) is dissolved in 4.0 ml of O, 1M glycine-g buffer (pH 10.5) and the pH is adjusted to 10
using 0.15 ml of 5 n. NaOH. 0.8 ml of the A-chain solution and 0.035 ml of the DTT solution at room temperature (25 ° C. 10 to provide an -SH ratio., - SS 0.91 are added to O, 5 of the B-chain solution. The resulting solution is stirred at 4 -8 ° C for 4 hours in an open vial. Analysis of the mixture by HPLC showed that bovine output
using 5 n. NaOH. B-tse-15 l-s-sulphonate is 1.96 mg or 30% of
In porcine insulin (300 mg), dissolved in 30 ml of 0.1 M glycine buffer (pH 10.5) and adjusted to pH 10.5 with 5N. NaOH. Dithiotrietol (DTT) (123.4 mg) is dissolved in 4 ml. OjIM glycine buffer (pH 10.5) and the pH of the mixture was adjusted to 10.5 with 0.2 t-ui 5 n. NaOH.
Solutions of the A and B chains are combined in CMfecb with a volume of 100 ml at room temperature (-25 ° C), and then 1.91 ml of dithiotrietol (DTT) are added to
ensure the ratio -8H „-830
| about
1.04; The resulting solution was gently mixed in an open beaker with a magnetic stirrer at 4-8 ° C for 20 hours. Analysis by high performance liquid chromatography indicates that the insulin yield is 193.8 mg, i.e. 29% of total protein.
40 ml of this solution was adjusted to pH 3.15 with acetic acid. The mixture was subjected to gel filtration on a Sephadex G-50 column (Superfine, Superfine) with dimensions of 5x200 cm, equilibrated and eluted with 1 M acetic acid at 4-8 C. The fractions containing insulin (elution volume about 2450-2700 ml), lyophiles were also combined - 95 mg of insulin is extracted with extraction, which is 25% of the total amount of protein. Pork insulin according to polyacrylamide gel electrophoresis, amino acid analysis, insulin radioreceptor analysis, liquid chromatography and recovery of rabbit blood glucose is a fairly pure product.
Example 2. Prepare solutions of S-sulfonates A-and b-chains of bovine insulin concentration of 5 mg / ml in 0.01 M glycine buffer (pH 10.5).
35
total protein.
Example 3. Prepare solutions of 8-sulfonates A-and b-chains of bovine insulin, having a concentration
20 ration 10 mg / ml, in 0.1 M glycine buffer (pH 10.5). The pH of each solution was adjusted to 10.5 with 5N. NaOH DTT (61.7 mg) is dissolved in 2.0 ml of water distilled in glass, K
25 0.5 ml of the B-chain solution are added with 0.6 ml of the A-chain solution and 29.25 ml of DTT solution at room temperature (25 ° C) to ensure an -SH-SSOj ratio of 1.00. The resulting
30, the solution was stirred at 4-8 ° C in an open vial of 3 m for 20 hours. Analysis of the HPLC mixture showed that the yield of porcine insulin was 3.81 mg or 35% of the total protein.
Example 4. B-chain S-sulfonate solutions of human (pancreatic) insulin and several human A-chain S-sulfonates (pancreatic and E. Coli) and porcine (pancreatic) insulins with a concentration of 5 mg / ml in 0.1 M glycine buffer are prepared. (pH 10.5). The pH of each solution is adjusted to 10.5.
45 using 5 n. NaOH. DTT (61.7 mg) was dissolved in 4.0 ml of OH, III of glycine buffer (pH 10.5) and the pH was adjusted to 10.5 by adding 0.16 ml of 5N. NaOH. To 1.0 ml of each solution of A-chain S-sulfonates, add 0.5 ml of B-chain S-sulfonate solution and 0.05 ml of DTT solution at room temperature (25 ° C) to ensure the ratio of SH -SSOj 1.09. All solutions are not
gg strand in a cool room
(4-8 C) in an open vial for 20-22 hours. Then they are analyzed using GHUR using pancreatic man as standard.
40
50
77902
The pH of each solution was adjusted to 10.5 with 5 H.-NaOH. DTT (61.7 mg) is dissolved in 4.0 ml of O, 1M glycine g buffer (pH 10.5) and the pH is adjusted to 10.5
using 0.15 ml of 5 n. NaOH. 0.8 ml of the A-chain solution and 0.035 ml of the DTT solution at room temperature (25 ° C) 10 are added to O, 5 ml of the B-chain solution, to provide the -SH ratio, - SSO 0.91. The resulting solution is stirred at 4-8 ° C for 4 hours in an open vial. Analysis of the mixture using HPLC showed that the output of the bovine ins5
total protein.
Example 3. Solutions of bovine insulin A-and B-chains of 8-sulfonates, having a concentration of 10 mg / ml, are prepared in 0.1 M glycine buffer (pH 10.5). The pH of each solution was adjusted to 10.5 with 5N. NaOH. DTT (61.7 mg) is dissolved in 2.0 ml of water distilled in glass, K
5 0.5 ml of the B-chain solution was added 0.6 ml of the A-chain solution and 29.25 ml of the DTT solution at room temperature (25 ° C) to ensure an -SH-1.SOj ratio of 1.00. The resulting
0, the solution was stirred at 4-8 ° C in an open vial with a volume of 3 m for 20 hours. Analysis of the HPLC mixture showed that the yield of porcine insulin was 3.81 mg or 35% of the total protein.
Example 4. Preparations of S-sulfonate B-chain of human (pancreatic) insulin and several S-sulfonates of A-chains of human (pancreatic and E.Coli) and porcine (pancreatic) insulins with a concentration of 5 mg / ml in 0.1 M glycine buffer ( pH 10.5). The pH of each solution is adjusted to 10.5.
5 using 5 n. NaOH. DTT (61.7 mg) was dissolved in 4.0 ml of OH, III of glycine buffer (pH 10.5) and the pH was adjusted to 10.5 by adding 0.16 ml of 5N. NaOH. To 1.0 ml of each solution of the S-sulfonates of the A-chains, add 0.5 ml of the B-chain S-sulfonate solution and 0.05 ml of the DTT solution at room temperature (25 ° C) to ensure that the -SH ratio -SSOj 1.09. All peg solutions are stirred in a cool room.
(4-8 C) in an open vial for 20-22 hours. Then they are analyzed using GHUR using pancreatic human as the standard
0
insulin to calculate yields.
The results are shown in Table. one.
Table 1
2, 00 26.7
2, 11 28.1
1, 95 26.0
2, 03 27.1
1.99 26.5
Example 5. Prepare a solution of each of the S-sulfonate A-and b-chains of human insulin concentration of 5 mg / ml in O, 1M glycine buffer (pH 10.5). The pH of each solution was adjusted to 10.5 with 5N. NaOH. DTT (61.7 mg) is dissolved in 4.0 ml of 0.1 M glycine buffer (pH 10.5) and the pH is adjusted to 10.5 with 0.16 ml of 5N. NaOH. 1.0 M of the A-chain solution is added to 0.5 ml of the B-chain solution at room temperature, and then 50 ml of the DTT solution is added to ensure that all eluted proteins are lyophilized. The insulin peak (elution volume 2465-2781 ml) weighs 125 g and represents 29.4% of the extracted protein.
A portion of the insulin peak (95.5 mg) is dissolved in approximately 9 ml of 0.01 M tris-0.001 EDTA-7.5 M urea — 0.03 NaCl buffer (pH 8.5 at). The mixture is subjected to chromatography through an ion exchange column of size
0,2,5x90 cm DEAE-cellulose (diethylaminoethyl), equilibrated with the same buffer. Protein is eluted at a NaCl concentration gradient of 0.03-0.09M in a volume of 1 liter in the same
Sc
Sheni -SHj-SSOj
equal to 1.09. I get- 45 snm buffer, and then 1 liter buffer,
The resulting solution is stirred at temp. containing 1 M NaCl. Each of the peaks
desalted on Sephadex G-25 (coarse) columns in 2% acetic acid and lyophilized. The insulin peak (elution volume 878-1008 ml) weighs 55.73 mg and constitutes 84% of the extracted protein.
Zinc-insulin crystals are obtained by dissolving an 11.90 mg sample of an insulin (DEAE) peak in 240 ml of 0.1N.
A 4-8 C in an open vial with a volume of 3 ml for 22 hours, after which the analysis by means of HPLC indicates that the yield of human insulin is 2.58 mg, which is 34% of the total protein.
Example 6. A human insulin A chain s-sulfonate (328 mg) was dissolved in 65.6 ml of 0.1 M glycine buffer (pH 10.5) and the mixture was adjusted to pH 10.5 with 75 ml of 5N. NaOH. Human insulin B chain s-sulfonate (164 mg) is dissolved in 32.8 ml O, 1 M glycine 50
55
HC1 followed by the rapid addition of 2.16 ml of a 0.04% ZnClg solution — 0.05 M sodium citrate — 15% acetone in a glass centrifuge
five
0
the second buffer (pH 10.5) and the pH of the mixture was adjusted to 10.5, adding 15 cells of 5 N to it. NaOH. DTT is dissolved in 4.0 ml of O, 1M glycine buffer (pH 10.5) and the solution is adjusted to pH 10.5 with 5N. NaOH.
Solutions of the A and B chains were combined in a 150 ml glass beaker at room temperature (25 seconds) and 3.28 ml of DTT solution was added to provide a ratio of 1.09. An open beaker is placed in an ice-water bath in a cool room and stirred vigorously for 10 minutes. Then the solution is stirred for 24 hours in a cool room (4–8 ° C). The analysis carried out at this time using LC5P determined a yield of 148 mg or 30% of the total protein.
25 ml of glacial acetic acid is added to 100 ml of this solution until the pH value is 3.15. All the material is subjected to gel filtration on a Sephadex G-50 column (Superfine) 5x200 cm in size, balanced and eluted with acetic acid at.
Q All eluted proteins are lyophilized. The insulin peak (elution volume 2465-2781 ml) weighs 125 g and represents 29.4% of the extracted protein.
A portion of the insulin peak (95.5 mg) is dissolved in approximately 9 ml of 0.01 M tris-0.001 EDTA-7.5 M urea — 0.03 NaCl buffer (pH 8.5 at). The mixture is subjected to chromatography through an ion exchange column of size
0,2,5x90 cm DEAE-cellulose (diethylaminoethyl), equilibrated with the same buffer. Protein is eluted at a NaCl concentration gradient of 0.03-0.09M in a volume of 1 liter in the same
B
50
Zinc-insulin crystals are obtained by dissolving an 11.90 mg sample of an insulin (DEAE) peak in 240 ml of 0.1N.
HC1 followed by the rapid addition of 2.16 ml of a 0.04% ZnClg solution — 0.05 M sodium citrate — 15% acetone in a glass centrifuge
test tube. Crystallization takes place for 72 hours at room temperature (25 ° C), after which the supernatant is recovered and the crystals are washed twice in cold water with a pH of 6.1 with centrifuging at 2000 rpm at 3 ° C between washes. The crystals were redissolved in 0.01 n. HC1 for analysis ..
The obtained human insulin preparation is considered completely pure after polyacrylamide electrophoresis. gel (single line), amino acid analysis, insulin radioreceptor analysis, insulin radio-immunoassay, HPLC, danilation, and UV spectroscopy. The blood test for rabbits gave an activity of 26.3 1.8 units. per mg of anhydrous substance.
PRI me R 7. A solution of human E. coli S-formyl-Gly insulin A-chain S-sulfonate and a solution of 5-mg / ml B-chain S-sulfonate of human B (chain) insulin were prepared. 01M glycine buffer (pH 10, -5). The pH of each solution was adjusted to 10.5 with 5N. NaOH. DTT (61.7 mg) is dissolved in 4.0 mg glycine buffer (pH 10.5). The pH was adjusted to 10.5 with 0.16 ml of 5 N, NaOH. To 1.5 ml of the B-chain S-sulfonate solution, 1, O ml of DTT solution is added at room temperature (25 ° C) to ensure the ratio of -3H-3SL 1.10. The solution is stirred in a cool room (4-8 ° C), in an open vial of 3 ml for 23 hours, after which it is analyzed by means of HPLC. The analysis shows that the yield (K-formyl-Gly -) - And human insulin is equal to 19.5% of the total protein.
After acidification to pH 3.15 with glacial acetic acid, a part of this solution is subjected to gel filtration on a 1.5x90 cm Sephadex C-50 (Supe Fayn) column, equilibrated and eluted with 1M acetic acid at 4-8 C. Peak (N-formyl-Gly) -A human insulin (elution volume 87-95 mp) is collected, an aliquot is taken from it, and the rest is lyophilized. The protein is considered pure based on the HPLC analysis and amino acid analysis. The biological activity (K-formyl-Gly) -A of human insulin is assessed using radioreceptor analysis; the activity is 17% relative to the human insulin standard.
Example 8. A solution of 10 mg Um of porcine S-sulfonate A-chain was prepared in 0.1 M glycine buffer (pH 10.5) and the same B-chain solution of human S-sulfonate (E. coli). A-B pool was prepared; a 2 m solution of A-chain per 1 ml of solution of pHA A-B pool was set equal to 10.5 using 5 n. NaOH. Cysteine (121.2 mg) was dissolved in 3.0 ml of 0.1 M glycine buffer (pH 10.5) and the pH of the resulting solution was set to 10.5 by adding 0.35 ml of 5N to it. NaOH. To a 1.4 ml A-B pool, 52 µl of a solution of cysteine was added at room temperature, in such a way that the ratio between -SH and -SSO was 0.95. The resulting solution was stirred at 4-8 ° C in an open test tube with a volume of 3 ml for 20 hours, after which an analysis was made of prolactin from human placenta. The human insulin yield was 3.25 mg (23.2% of the total protein content).
Example 9. The x-ray analysis of human insulin, obtained as a semi-synthetic (NOVO) method, and the method of recombinant DNA (LiLL). Crystals of human insulin have a combohedral cell of the space group R, 85 A, C 34.1 A and are almost isomorphic to the crystals of pig 2-insulin (, 50 A, 0 A).
The exact photographs of the human insulin crystals obtained by the wallpaper and by the methods are not different from each other and from the pancreatic human insulin, however, there are noticeable differences in the intensity distribution between human insulin and pig insulin.
A thorough crystallographic calculation of both NOVO and LL insulins using the 1.9A resolution performed by the fast Fourier least squares method shows that, within the experimental error, the structures of both human insulins are identical and very close to pig insulin except for C-con chain B. After optimization, the differences in the arrangement of atoms in human insulin NOVO and LiLL are: 0.15 A only for the base atoms
chains and 0.22 A for all atoms. These differences are smaller than the differences between the Two molecules in dimer 2 of Zn-insulin pig. The conformation of the B29 lysine side chain is well defined for both molecules, with two different conformations found in the pig insulin molecule. The atoms of the main chain of the OZO in both molecules are substantially shifted, in particular, in carboxyl groups. Changes in the structure of water were also found when comparing the crystal structures of human insulin and pig insulin in the B28-VZO region.
The effect of protein concentration on the reaction of compounds of chains AB.
Purpose: a detailed assessment of the optimal total concentration of protein chains in the reaction of the compound A + B chains of human insulin. Method: get 7 ml of solution A (SSOj) from pig with a concentration of 25 mg / ml and 4 ml of solution B (SSO) from E. coli (B-gal) with a concentration of 25 mg / ml in 0.1M glycine buffer with pH 10 ,five. 6.0 ml of A-chain solution and 3.0 ml of B-chain solution are combined. The combined solution is then adjusted to pH 10.5 with 5N. NaOH. DTT is obtained by dissolving 61.7 mg in 4.0 MP of 0.1 M glycine buffer with a pH of 10.5, and again adjusted to pH id, 5 with 140 µl of 5N. NaOH. 1.64 ml of DTT solution was added to the combined A / B chains solution.
The optimal ratio of SH / SSOJ 1, .20 was previously determined with the same DTT and chains at a protein concentration of 10 mg / ml. The concentration of 40 proteins in the reaction of combining A + B chains should not significantly affect the optimal content of DTT.
protein concentration in each sample.
The results above show the presence of a real, well-defined optimum to a protein concentration of 8 mg / ml for the reaction of linking human albumin chains.
PH test: Compound A + B cysteine.
Purpose: to evaluate the optimal pH value for the reaction of Compound A + B + cysteine
Method: Combine 10 ml of A-chain solution and 5 ml of B-chain solution in 0.1 M glycine buffer with pH 10.5. f5 A solution of cysteine is obtained by dissolving 121.2 mg in 3.0 ml of glycine buffer and then adjusting the pH to 10.5 with 350 μl 5 n. NaOH. Aliquots of this combined 20 A / B solution, having a volume of 1.4 ml, are adjusted at room temperature to the pH values indicated below. 57 µl of cysteine solution is added, after which the pH is immediately adjusted to the initial value. After that, each sample is placed in a cold room (6 ° C) and stirred overnight in a 3-milliliter vial.
thirty
35
Results: A HPLC analysis was carried out after 24-27 hours of reaction at 6 ° C using aliquots diluted with glacial acetic acid 1: 2. The actual yields in the chain coupling reaction are calculated. Dependence on pH reveals a clear optimum around pH 10.5.
Conclusion: in the reaction of compound A + B + + cysteine, a clear optimum was found at pH 10.5.
PH test: Compound A + B.
Purpose: A detailed assessment of the pH range around the pH value of 10.5 at the beginning
the reaction of the connection of the chains A + B for op-Solution, in which the re-
pH value and exact optimum pH value leading to optimal insulin yield.
Method: 120 mg porcine A (SSOj)
The shares of the compound are immediately divided into aliquots and placed in 11 3 ml ampoules containing various amounts of O, 1 M glycine buffer. Each vial is agitated for 50 human B (SSOJ) at night when emitted from E. coli (trp E), the actual total concentration is ryt in 12.0 and 6.0 ml chains, respectively, takes into account the amino acid analysis (88, 8 wt.% A-chain, 88 may.% B-chain), as well as the addition of DTT and in 5 n. NaOH.
these dilution factors. 1/27 HPLC- 61.7 mg DTT was dissolved in 4.0 mp. The analysis was carried out immediately after 0.1 M glycine buffer was applied and the reaction was again completed for 22-25 hours. 5 using 140 μl of the output is calculated on the basis of de - 5 n. NaOH.
0.1 M glycine buffer pH 10.5 and again adjusted to pH 10.5 with
ABOUT
concentration of protein in each sample.
The results above show the presence of a real, well-defined optimum to a protein concentration of 8 mg / ml for the reaction of linking human albumin chains.
PH test: Compound A + B cysteine.
Purpose: assessment of the optimal value. pH for the reaction of compound A + B + cysteine.
Method: Combine 10 ml of A-chain solution and 5 ml of B-chain solution in 0.1 M glycine buffer with pH 10.5. 5 A solution of cysteine is obtained by dissolving 121.2 mg in 3.0 ml of glycine buffer and then adjusting the pH to 10.5 with 350 μl of 5N. NaOH. Aliquots of this combined 0 A / B solution, having a volume of 1.4 ml, are brought at room temperature to the pH values indicated below. 57 µl of cysteine solution is added, after which the pH is immediately adjusted to the original 5 value. After that, each sample is placed in a cold room (6 ° C) and stirred overnight in a 3-milliliter vial.
40
thirty
35
Results: A HPLC analysis was carried out after 24-27 hours of reaction at 6 ° C using aliquots diluted with glacial acetic acid 1: 2. The actual yields in the chain coupling reaction are calculated. Dependence on pH reveals a clear optimum around pH 10.5.
Conclusion: in the reaction of compound A + B + + cysteine, a clear optimum was found at pH 10.5.
PH test: Compound A + B.
Purpose: A detailed assessment of the pH range around the pH value of 10.5 at the beginning
rn respectively in 12.0 and 6.0 ml of 5 n. NaOH.
0.1 M glycine buffer pH 10.5 and again adjusted to pH 10.5 with
These solutions are stored in ice packs during the preparation of individual reaction samples. Each sample is completely completed before starting the preparation of the sample.
The following experiment was performed by adding reagents in a given order to open 3-ml ampoules and mixing in a cold room (6 s) using a magnetic stirrer.
Bringing the pH is very accurate.
fast and listed below
The pH adjustment is the exact initial pH at 6 ° C, at which the reaction is initiated and carried out.
Results; after reaction for 4-5 hours, several samples were subjected to direct analysis by HPLC. After reaction for 1 day, all samples were analyzed by HPLC.
Data HPLC, calculated relative to the HPLC analysis of standard pig insulin.
The data presented clearly shows that a pH of 10.5 corresponds to the optimum for starting the reaction of compound A + B.
Experiments have shown that pH is an extremely important factor in determining good insulin yields. An initial pH of 10.5 at this reaction temperature must be observed in all other reactions of the compound.
In order to maximize the insulin yield, it is no longer necessary to maintain the initial pH of the reaction to 10.5.
Experiment on the reaction of the connection of the pig chain A (human chain B (detect / -
re is fairly reproducible
compound yields: 23.6; 24.7 | 23.5; 23.0; 23.0 and 23., 1% with an average yield of 23.5%.
Conclusions: this experiment clearly shows that the optimum pH value is 10.5, and that the initial pH value plays a decisive role in the reaction of compound A + B.
The reaction of the compound A + B and cysteine (CIS).
Objective: Determine whether cysteine can be used as an amino acid.

0
five
0
five

0
a reducing thiol of an inexpensive agent in the reaction of combining the A + B chains.
Method: porcine A (SSOj) and E.Co-11 V (SSOj) g, is used to obtain a mixed solution of A / B with a concentration of 10 mg / ml in glycine buffer with a pH of 10.5.
A solution of L-cysteine in the form of a free base (mp 121.21) is prepared by dissolving 121.2 mg in 3.0 ml of 0.1 M glycine buffer, after which the pH is adjusted to 10.5 with 350 µl 5 n. NaOH.
Different amounts of cysteine are added to 1.4 ml of the apiquots of the mixed A / B solution at pH 10.5. Through 17-21. The reaction was carried out at b ° C using a HPLC analysis.
Results: SH / SSO dependency obtained, typical of many dependencies for DTT. The optimum yield, equal to 23.3%, is well comparable with the protein yield, equal to 24-27% and obtained with DTT. Optimal yields for both DTT and cysteine were obtained at the same ratio. ZN / 350z 1.2.
Results: in the reaction of the connection of the A + B chains, cysteine works the same as DTT. .
Reaction of Compound A + B with mercaptopropionic acid and with mercaptopic succinic acid.
Objective: To determine whether γ-mercaptopropionic acid (abbreviated as IPC) or mercapto-succinic acid (abbreviated MEAC) can be used as thiol reducing agents in the reaction of the connection of the A + B chains.
Method: porcine A (SSOJ) and E. coli-11 (SSOj) 2 is used for production. mixed solution A / B with a total concentration of 10 mg / ml in a glycine buffer, 45 pH 10.5. 1.4 ml of this A / B mixed solution is used for each sample.
-Mercaptopropionic acid is used in the form of a solution of 87 µl of this 50 acid in 4.0 ml of glycine buffer, the pH being adjusted to 10.5 with 200 µl of 5N. NaOH, M ercapto succinic acid is used in the form of a solution of 150.1 mg of this acid in 3.5 ml of glycine-55 buffer, the pH being adjusted to 10.5 with 700 µl of 5N. NaOn.
Results: each sample was stirred overnight at 6 ° C. and subjected to HPLC analysis.
11 1327790 12
 -Mercaptopropionic acid at- (mercaptoeth1-shamine) as an acceptable insulin code, and mercapto-succinic acid gives very poor yields. The optimal value for IPC SH / SSOj is 1.40 and it is higher than in previous studies with these chains (insulin yield 16%.).
Conclusions: -Mercaptopropionic acid is reasonably effective in reacting the connection of the A + B chains, and mercapto-tartaric acid as a decarboxylated thiol agent is very poor.
Mercaptoacetic acid and ortho-mercaptobenzoic acid.
Purpose: to determine whether mercaptoacetic acid (MUK) or ortho-mercaptobenzoic acid (MBC) can be used as a thiol-reducing reagent in the reaction of connecting the A + B chains.
Method: pork A (SSO). and E.Co-11 V (SSO) is used to obtain a mixed A / B solution with a concentration. Conclusion: Mercaptoethanol and cystamine are not effective in the reaction of the compound
10 mg / ml in glycine buffer with 25 A + B chains. pH 10.5. For each sample, use Compound A + B: cysteine, 1.4 ml each of this mixed A / B, compared with DTT.
solution. Purpose: comparison of cysteine and DTT in
Mercaptoacetic acid using compound A + B reactions efficiently, in a solution of 71 µl of this acid, compound of chains A and B. in 3.9 ml of glycine buffer, method: solutions of chains A, B and combined solution A / B is obtained in glycine buffer (O, 1M) with a pH of 10.5. The difference in the number of cystech solution was adjusted to pH 10.5 with 300 µl 5 n. NaOH. Ortho-mercaptobenzoic acid is used in the form of a solution of 154.2 mg of this acid in 3.8 ml of glycine buffer, the pH being adjusted to 10.5 with 400 µl of 5N. NaOH.
Results: each sample was stirred overnight and subjected to HPLC analysis. Then insulin output is calculated.
Mercaptoacetic acid compared with DTT and cysteine leads to
Method: solutions of chains A, B and the combined solution A / B are obtained in glycine buffer (O, 1M) with a pH of 10.5. The difference in the number of solutions of cysteine35 or DTT is added to 1.4 ml.
aliquots of the combined A / B solution and mixed in 3 ml open ampoules overnight at 6 C. Results: yield calculations were performed, HPLC analysis and calculations
SH / SSO. The maximum insulin yield in the reaction of compound A + B is 94% of the maximum yield, yielding
50
Mogo with DTT. However, the peak of dependence is good for insulin yields, although in 45 from SH / SSO: for cysteine, the wider case is the optimum ratio of SH / SSO (1.0 to 1.5) than for DTT, (1.2 to 1.3) and very wide (1.2-2.0, yield 19.7-20.5%). Outputs using ortho-mercapto-benzoic acid are significantly lower (up to 8.6%).
Conclusion: in the reaction of compound A + B, Mercaptoacetic acid is very effective, and ortho-mercaptobenzoic acid is much less effective.
Reaction of Compound A + B with Mercapto-Eg Temperature Study: Reactanol-OR Cystamine. Compound A + B.
Objective: to determine whether J-Mercaptoethanol or cystamine can be used in the reaction of the A + B chains.
this determines the advantage of the production method.
Conclusions: cysteine leads only to 90-95% of the maximum yield, but gives a wider peak of dependence on SH / SSOj as compared to DTT in the reaction of joining the A + B chains.
Objective: To study the dependence of the reaction rate and insulin yield when the A + B chains are connected to a human insulin thiol agent.
Method: pork A (SSO) and B (SSOj) 2 from E. coli are used for
obtaining a mixed solution of A / B with a concentration of 10 mg / ml in glycine buffer with a pH of 10.5. 1.4 ml of this A / B mixed solution is used for each sample.
Α-Mercaptoethanol is used as a solution of its 70 µl in 4.0 glycine buffer, the pH being adjusted to 10.5 with 200 µl 5 n. NaCH.
Results: each sample is stirred overnight at and subjected to HPLC analysis. Insulin yield is calculated. The optimum ratio of SH / SSO is 1.25 for both dl and mercaptozyl; Ina and coincides with the optimum for DTT n cysteine, however, the maximum insulin yields (8–9%) are significantly lower.
Conclusion: Mercaptoethanol and cystamine are not effective in the reaction of the compound.
chains A + B. Reaction of Compound A + B: Cysteine versus DTT.
 reactions of compound A + B in terms of the efficiency of the connection of chains A and B.
Method: solutions of chains A, B and the combined solution A / B are obtained in glycine buffer (O, 1M) with a pH of 10.5. The difference in the number of solutions of cysteine35 or DTT is added to 1.4 ml.
aliquots of the combined A / B solution and mixed in 3 ml open ampoules overnight at 6 C. Results: yield calculations were performed, HPLC analysis and calculations
SH / SSO. The maximum insulin yield in the reaction of compound A + B is 94% of the maximum yield, yielding 0
Mogo with DTT. However, the peak of dependence of 45 on SH / SSO: for cysteine is wider (1.0-1.5) than for DTT, (1.2-1.3) and
this determines the advantage of the production method.
Conclusions: cysteine leads only to 90-95% of the maximum yield, but gives a wider peak of dependence on SH / SSOj as compared to DTT in the reaction of joining the A + B chains.
Purpose: to study the dependence of the reaction rate and insulin yield when connecting the A + B chains of human insulin on the temperature of the reaction.
Method: 149 mg A (SSOJ) from pig and 70 mg B (SSOj) from E. coli trp E are dissolved in 14.9 and 7.0 ml of 0.1 M glycine buffer, respectively, and adjusted to pH 10.5 s. using 5 n. NaOH. DTT is obtained at a concentration of 61.7 mg in 4.0 ml of buffer and adjusted to pH 10.5 with 140 µl of 5N. NaOH.
Samples of the three reactions of the compound are obtained at different temperatures in 15 ml ampoules as indicated below. All solutions are cooled to -1 ° C. In this series of experiments, 0, and SH / SSOJ 1.11.
At various times, these samples after dilution 1: 2
acetic acid is checked for content not directly related to the final
zhivaniya human insulin using ghvd-8/25 analysis. Quantitative assessment is based on the analysis of pig insulin at 15.5,
Results: after 1 day. samples are again evaluated to determine the final insulin yield.
- Analysis of the results shows that at room temperature the reaction of the compound starts to proceed very quickly, but within a short period of time (3 hours), the formation of insulin stops at a low insulin yield (9.8%), the maximum is reached in 3-5 hours, the insulin content slowly falls (after 22 h, the yield is 4.8%). At 6 ° C, the insulin formation reaction proceeds somewhat faster than at 0 s up to a reaction time of 6 hours, however, the final yields at the reaction time of 23 hours are almost the same (24.4 and 24.7%, respectively). With the exception of carrying out the reaction at room temperature, no decomposition of insulin was detected due to disruption of the disulfide bonds up to a reaction time of 24 hours.
Based on the reaction dependencies in the table. 2, are given for each reaction of the compound or the time at which half of the maximum insulin yield is reached.
T a
faces
Dependence t
/ 2 Amaks
FROM
temperature is a straight line. Therefore, the temperature is inversely proportional to t ,, but it does not
insulin output.
Conclusions: Conducting the interaction of compounds A + B at 0 ° C compared with the process in a cold room (6 ° C) slows down the reaction somewhat, however, leads to the same final insulin yield (24-25%). Conducting the reaction of the compound at room temperature leads to a decrease in yield. The reaction of joining A + B chains should be optimally carried out at 0-6 C for 24 hours.
The implementation of the proposed method allows to increase the yield up to 25% from 1-2% and simplify the process by carrying out the process of interaction of S-sulfonates of the A and B chains of insulin in one apparatus in a single-phase solvent.

权利要求:
Claims (1)
[1]
Invention Formula
The method of obtaining human insulin or its analogs by the interaction of the S-sulfonate of the A-chain of human insulin or its analog with the S-sulfonate of the B-chain of human insulin, or its analog in an aqueous medium in the presence of a thiol reducing agent and oxygen that, in order to simplify the process and increase the yield of the target product, the process is carried out in the presence of a thiol reducing agent selected from the group consisting of dithiotrietol, dithioerythrol, mercaptoacetic acid, f - erkaptopropiono
151327790 16
acid or cysteine, in a thief of 5–10 mg / ml, in a mass ratio of 8–15 wt.% of the total A-chain and B-chain colony 1: 1.5–2: 1 with S A-chain and B-chain sulphonates, pH 9-11.5, temperature 0–22 s in those with a total protein concentration of 0.5–24 h.

类似技术:

---

公开号 | 公开日 | 专利标题

---

US4421685A|1983-12-20|Process for producing an insulin

---

Hughes et al.1949|Preparation and properties of serum and plasma proteins. XXII. A crystallizable guanidinated derivative of human serum albumin

---

Zhuang et al.1984|Characterization of potent sodium/proton exchange inhibitors from the amiloride series in A431 cells

---

Li et al.1974|Human pituitary growth hormone isolation and properties of two biologically active fragments from plasmin digests

---

Colosi et al.1982|Isolation, purification, and characterization of mouse placental lactogen

---

RU1802814C|1993-03-15|Method of peptidylglycine @@@-amidating monooxygenase purification and a method of @@@-amidated peptide preparation

---

Tashjian Jr et al.1964|Alkylation and oxidation of methionine in bovine parathyroid hormone: effects on hormonal activity and antigenicity

---

Levy et al.1967|The synthesis of triaminoacyl-insulins and the use of the t-butyloxycarbonyl group for the reversible blocking of the amino groups of insulin

---

Matthews et al.1972|Evidence for the presence of two nonidentical subunits in carbamyl phosphate synthetase of Escherichia coli

---

Cheah et al.1980|Target tissues for relaxin in the rat: tissue distribution of injected 125I-labeled relaxin and tissue changes in adenosine 3′, 5′-monophosphate levels after in vitro relaxin incubation

---

Janmey et al.1986|Sequential binding of actin monomers to plasma gelsolin and its inhibition by vitamin D-binding protein

---

Frank et al.1972|Insulin and proinsulin conformation in solution

---

SU1327790A3|1987-07-30|Method of producing manъs insulin or analogues thereof

---

EP0844484B1|2003-06-18|Method for producing a stable troponin preparation and the use thereof as a calibrator/control in immunoassays

---

Grigorian et al.2005|Extraordinarily stable disulfide‐linked homodimer of human growth hormone

---

BREUER1969|Stimulation of DNA Synthesis in Cartilage of Modified Placental Lactogen and Anabolic Hormones

---

Odorzynski et al.1979|Refolding of the mixed disulfide of bovine trypsinogen and glutathione.

---

Chen-Kiang et al.1977|Homology between a prolyl hydroxylase subunit and a tissue protein that crossreacts immunologically with the enzyme

---

Helmerhorst et al.1987|Self-association of insulin: Its pH dependence and effect of plasma

---

Huang et al.1975|Calcium-binding protein of bovine intestine. The complete amino acid sequence.

---

HANDWERGER et al.1972|Correlations in the structure and function of human placental lactogen and human growth hormone. I. Modification of the disulfide bonds

---

Li1975|Human pituitary growth hormone: a biologically active hendekakaihekaton peptide fragment corresponding to amino-acid residues 15-125 in the hormone molecule

---

SOMAN et al.1977|Studies of the composition and radioreceptor activity of “big” and “little” human growth hormone

---

Deisseroth et al.1969|The purification and crystallization of beef erythrocyte catalase

---

Sperling et al.1974|Simultaneous reduction and mercuration of disulfide bond A6-A11 of insulin by monovalent mercury

同族专利:

---

公开号 | 公开日

---

PT72733B|1982-03-22|

---

NO151897C|1985-06-26|

---

EP0037256B1|1983-09-14|

---

PL230295A1|1981-11-13|

---

DD157613A5|1982-11-24|

---

FI810918L|1981-09-28|

---

PH16153A|1983-07-12|

---

ZA811970B|1982-11-24|

---

IL62483D0|1981-05-20|

---

AR227305A1|1982-10-15|

---

IL62483A|1984-05-31|

---

IE810680L|1981-09-27|

---

IE51608B1|1987-01-21|

---

GB2072680B|1983-09-21|

---

HU185416B|1985-02-28|

---

CA1155109A|1983-10-11|

---

DK136581A|1981-09-28|

---

AU540645B2|1984-11-29|

---

RO81640A|1983-04-29|

---

JPS56154443A|1981-11-30|

---

PT72733A|1981-04-01|

---

ES8207551A1|1982-09-16|

---

YU76981A|1983-09-30|

---

PL128599B1|1984-02-29|

---

CS236463B2|1985-05-15|

---

DK149756B|1986-09-22|

---

NZ196610A|1984-03-16|

---

AU6884481A|1981-10-01|

---

NO151897B|1985-03-18|

---

EG15248A|1985-12-31|

---

ES500750A0|1982-09-16|

---

GR73619B|1984-03-26|

---

GB2072680A|1981-10-07|

---

RO81640B|1983-04-30|

---

AT4638T|1983-09-15|

---

EP0037256A1|1981-10-07|

---

KR830004855A|1983-07-20|

---

DE3160862D1|1983-10-20|

---

JPS6318960B2|1988-04-20|

---

NO811038L|1981-09-28|

---

KR840000947B1|1984-07-01|

---

DK149756C|1987-06-15|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

---

US4451396A|1983-08-01|1984-05-29|Eli Lilly And Company|Process for inhibiting undesired thiol reactions during cyanogen bromide cleavage of peptides|

---

DE3501641A1|1985-01-19|1986-07-24|Hoechst Ag, 6230 Frankfurt|METHOD FOR OBTAINING INSULIN PRECURSORS FROM REACTION MIXTURES WHICH ARE INCLUDED IN THE FOLDING OF INSULIN PRECURSORS FROM THE CORRESPONDING S-SULPHONATES|

---

US4835251A|1986-06-23|1989-05-30|Genetech, Inc.|Method of chain combination|

---

GB8927546D0|1989-12-06|1990-02-07|Ciba Geigy|Process for the production of biologically active tgf-beta|

---

JP2606100Y2|1992-04-15|2000-09-11|松下電器産業株式会社|Vacuum cleaner and its pack filter|

---

JP3406244B2|1999-04-30|2003-05-12|伊藤ハム株式会社|Method for producing recombinant insulin from novel fusion protein|

法律状态:

优先权:

---

申请号 | 申请日 | 专利标题

---

US13439080A| true| 1980-03-27|1980-03-27|

---